# Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients

> **NCT06512831** · NA · COMPLETED · sponsor: **West China Hospital** · enrollment: 1348 (actual)

## Conditions studied

- Kidney Transplantation
- Tuberculosis
- Isoniazid Toxicity

## Interventions

- **DRUG:** Isoniazid

## Key facts

- **NCT ID:** NCT06512831
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-01
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 1348 (ACTUAL)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06512831

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06512831, "Isoniazid Prophylaxis Based on Risk Factors of Tuberculosis in Living Kidney Transplantation Recipients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06512831. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*